Exelon
EXC
$48.66
+1.06%
Exelon Corporation is a major American utility holding company that operates six regulated electric and gas utilities serving approximately 10 million customers across Illinois, Pennsylvania, Maryland, New Jersey, Delaware, and Washington, D.C. The company is a dominant player in the regulated electric utility industry, deriving its earnings from rate-regulated operations that provide stable cash flows. The current investor narrative centers on the company's execution of a substantial capital expenditure program to modernize its grid infrastructure and support the energy transition, while navigating the regulatory approval processes for rate cases that are critical for earning its authorized returns and funding future investments.…
EXC
Exelon
$48.66
Investment Opinion: Should I buy EXC Today?
Rating & Thesis: Hold. Exelon is a stable, defensive utility with a manageable but not compelling risk/reward profile at current levels; the core thesis is that its substantial capital investment program is already reflected in its valuation, leaving limited near-term catalysts for outperformance. This aligns with the mixed but leaning-bullish analyst sentiment, which includes 'Outperform' and 'Buy' ratings balanced by 'Neutral' and 'Underweight' stances.
Supporting Evidence: The stock trades at a reasonable forward P/E of 15.94x, which is likely at a slight discount to many utility peers that often trade in the 17x-20x range. It offers a solid 3.67% dividend yield with a sustainable 58.4% payout ratio. Profitability metrics are healthy, with an ROE of 9.61% and an operating margin of 21.21%. However, these positives are counterbalanced by negative TTM Free Cash Flow of -$2.28B and modest revenue growth challenges, as seen in the recent -1.08% YoY decline.
Risks & Conditions: The two biggest risks are the unsustainable cash burn funding its capex plan and regulatory setbacks that could impair future earnings growth. This Hold rating would upgrade to a Buy if the forward P/E compressed below 14x on market weakness, or if the company demonstrates a clear path to positive free cash flow generation within the next 12 months. It would downgrade to a Sell if the debt-to-equity ratio rises above 2.0 or if revenue growth decelerates further into negative mid-single digits. Based on the current data, EXC appears fairly valued relative to its own history and the regulatory utility sector's growth prospects.
Sign up to view all
EXC 12-Month Price Forecast
Exelon presents a classic 'steady Eddie' utility profile with embedded execution risk. The neutral stance reflects a balance between its defensive attributes (low beta, 3.67% yield) and the significant financial strain of its investment phase (negative FCF, D/E of 1.76). The base case of modest, range-bound returns is most probable, as the stock's valuation already prices in a successful regulatory outcome. The stance would upgrade to Bullish on evidence of regulatory wins that accelerate the path to positive FCF or a market correction that pushes the P/E below 14x. It would downgrade to Bearish if quarterly cash burn accelerates or a major rate case is unexpectedly denied.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Exelon's 12-month outlook, with a consensus price target around $63.26 and implied upside of +30.0% versus the current price.
Average Target
$63.26
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$39 - $63
Analyst target range
Exelon is covered by a modest cohort of 6 analysts, indicating solid but not extensive institutional interest for a large-cap utility. The consensus sentiment leans bullish, as evidenced by recent institutional ratings which include actions like 'Outperform' from Evercore ISI, 'Buy' from Jefferies, and 'Overweight' from Barclays and Wells Fargo, balanced by 'Neutral' from JP Morgan and UBS and an 'Underweight' from Keybanc. The average target price and implied upside cannot be calculated from the provided data, as only estimated EPS and revenue figures are given without explicit price targets, so the strength of the bullish lean is qualitative based on the distribution of recent recommendations. The range of analyst estimates provides a signal on uncertainty; for example, the estimated EPS for the period ranges from a low of $3.59 to a high of $3.82, a relatively tight spread of about 6.4%, which suggests stronger conviction in the company's earnings power. The high estimate likely assumes successful regulatory outcomes and efficient capital deployment, while the low estimate may factor in potential rate case delays or higher-than-expected costs, with the recent pattern of reiterated ratings indicating analysts are in a 'wait-and-see' mode pending execution on the large investment plan.
Bulls vs Bears: EXC Investment Factors
The investment debate for Exelon centers on a clash between its stable, defensive utility profile and the significant financial strain of its capital-intensive growth strategy. The bull case is stronger on stability, anchored by a low beta of 0.505, solid profitability (21.21% operating margin), and a reasonable P/E of 15.9x that is not demanding. However, the bear case presents a more immediate and quantifiable risk through a severe -$2.28 billion free cash flow burn and high debt (D/E of 1.76). The single most important tension is whether the company's massive capital expenditure program will successfully translate into future rate-based earnings growth sufficient to justify the current financial strain, or if the cash burn and leverage will constrain returns and shareholder value for an extended period.
Bullish
- Defensive Profile with Low Beta: EXC's beta of 0.505 indicates it is roughly half as volatile as the broader market, providing a defensive anchor for portfolios. This characteristic, combined with its regulated utility model, offers predictable cash flows and relative stability during market downturns, as evidenced by its 12.17% 3-month gain while the S&P 500 fell 2.1%.
- Strong Profitability & ROE: The company maintains solid core profitability with a trailing twelve-month operating margin of 21.21% and a Return on Equity of 9.61%. This demonstrates efficient use of shareholder capital to generate earnings, supporting the sustainability of its operations and its 3.67% dividend yield.
- Reasonable Valuation vs. History: EXC trades at a trailing P/E of 15.92x, which sits near the lower end of its own historical range observed in the data (7x to 29x). This suggests the stock is not priced for excessive optimism and may offer relative value if earnings stabilize, especially given its forward P/E of 15.94x implies expectations for stable, low-single-digit growth.
- Analyst Conviction in Earnings: Analyst EPS estimates for EXC show a tight range, with a high of $3.82 and a low of $3.59—a spread of only 6.4%. This narrow band indicates strong conviction in the company's near-term earnings power, reducing the risk of significant earnings surprises.
Bearish
- Severe Negative Free Cash Flow: EXC's trailing twelve-month free cash flow is deeply negative at -$2.28 billion, driven by heavy capital expenditures like the -$2.43 billion in Q4 2025. This massive cash burn necessitates external financing and limits financial flexibility, raising concerns about funding its large investment program without diluting shareholders or increasing debt.
- Revenue Contraction & Volatility: Q4 2025 revenue of $5.41 billion represents a -1.08% year-over-year decline, and quarterly results show high volatility (e.g., Q3 revenue was $6.71B). This lack of consistent top-line growth, coupled with an anomalous Q4 gross margin of -21.62%, highlights operational and seasonal challenges.
- Significant Underperformance vs. Market: EXC has dramatically lagged the broader market, with a 1-year relative strength of -21.87 versus the S&P 500. This underperformance suggests the stock is out of favor with growth-oriented capital, and its 7.65% annual gain is insufficient to attract momentum investors in a bull market.
- High Debt Load for Capital Intensity: The company carries a debt-to-equity ratio of 1.76, which is typical but substantial for a capital-intensive utility. This leverage increases interest rate sensitivity and financial risk, especially in a rising rate environment, as it must service this debt while funding a multi-billion dollar capex plan.
EXC Technical Analysis
Exelon's stock has been in a sustained uptrend over the past year, evidenced by a 7.65% one-year price change, but this performance has significantly lagged the broader market, as indicated by a relative strength of -21.87 versus the S&P 500. The stock is currently trading at $48.57, which is approximately 79% of its 52-week range ($41.71 to $50.65), positioning it closer to the upper bound and suggesting momentum but also potential overextension near resistance. Recent short-term momentum is mixed, with a strong 12.17% gain over the past three months contrasting with a slight 0.55% decline over the past month, indicating a potential consolidation or pullback after a sharp rally. This divergence from the longer-term trend could signal a temporary pause as the stock digests its recent gains, especially given its low beta of 0.505, which implies it is roughly half as volatile as the market. Key technical levels are clearly defined, with major support at the 52-week low of $41.71 and immediate resistance at the 52-week high of $50.65; a decisive breakout above $50.65 would signal a resumption of the bullish trend, while a breakdown below $41.71 would invalidate the uptrend. The stock's low beta of 0.505 indicates it is a defensive, low-volatility holding, which is typical for a regulated utility and matters for investors seeking stability and income, though the recent price action shows it can still experience significant moves within its defined range.
Beta
0.51
0.51x market volatility
Max Drawdown
-11.1%
Largest decline past year
52-Week Range
$42-$51
Price range past year
Annual Return
+3.8%
Cumulative gain past year
| Period | EXC Return | S&P 500 |
|---|---|---|
| 1m | -2.3% | +4.9% |
| 3m | +11.6% | +0.6% |
| 6m | +2.7% | +5.1% |
| 1y | +3.8% | +28.8% |
| ytd | +10.8% | +1.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
EXC Fundamental Analysis
Exelon's revenue trajectory shows modest year-over-year contraction, with Q4 2025 revenue of $5.41 billion representing a -1.08% decline from the prior year's quarter, though quarterly results have been volatile with Q3 2025 revenue at $6.71 billion. The revenue segment data reveals a diversified utility base, with PECO Energy Co ($2.13B) and Pepco Holdings LLC ($1.73B) being the largest contributors, while the overall trend reflects the seasonal and weather-dependent nature of utility earnings. The company is consistently profitable, with Q4 2025 net income of $594 million and a net margin of 10.98%, though profitability fluctuates quarterly as seen in the jump from a net margin of 7.20% in Q2 to 13.05% in Q3. Gross margin was an anomalous -21.62% in Q4 due to a negative gross profit, but the trailing twelve-month operating margin is a healthier 21.21%, indicating core utility operations remain solidly profitable despite quarterly accounting variances. The balance sheet carries a significant but manageable debt load, with a debt-to-equity ratio of 1.76, which is typical for capital-intensive utilities that leverage regulated asset bases. Free cash flow over the trailing twelve months is deeply negative at -$2.28 billion, which is expected for a utility in a heavy investment phase, as evidenced by substantial capital expenditures like the -$2.43 billion in Q4 2025; this negative FCF is funded through operating cash flow ($1.24B in Q4) and external financing, with an ROE of 9.61% indicating adequate returns on shareholder equity.
Quarterly Revenue
$5.4B
2025-12
Revenue YoY Growth
-0.01%
YoY Comparison
Gross Margin
-0.21%
Latest Quarter
Free Cash Flow
$-2.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is EXC Overvalued?
Given Exelon's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 15.92x and a forward PE of 15.94x, based on estimated EPS; the near-identical values suggest the market expects stable, low-single-digit earnings growth, which is consistent with a regulated utility profile. Compared to sector averages, Exelon's valuation appears reasonable; while specific industry average multiples are not provided in the data, a trailing PE around 16x is generally in line with or at a slight discount to many regulated utility peers, which often trade in the 17x-20x range, implying the market is not assigning a premium for its growth profile. Historically, Exelon's current trailing PE of 15.92x sits below its own historical range observed in the data, which has seen quarterly PE ratios fluctuate from around 7x to over 29x over the past several years; this positioning near the lower end of its historical band suggests the stock is not priced for excessive optimism and may offer relative value if earnings stabilize, though it also reflects the market's caution regarding execution risks and regulatory outcomes.
PE
15.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -26x~30x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are centered on cash flow and leverage. The company is burning cash at an alarming rate, with TTM Free Cash Flow of -$2.28B, necessitating heavy reliance on debt and external financing to fund its -$2.43B quarterly capex. This is compounded by a substantial debt-to-equity ratio of 1.76, which increases interest expense sensitivity. Furthermore, revenue is volatile and recently contracted YoY by -1.08% in Q4, and profitability is inconsistent, with net margin swinging from 7.20% in Q2 to 13.05% in Q3, indicating earnings are not yet on a stable, predictable path.
Market & Competitive Risks stem from its valuation and macro sensitivity. While its P/E of 15.9x is reasonable, the stock has dramatically underperformed the S&P 500 by -21.87% over the past year, signaling it is out of favor and vulnerable to further sector rotation away from utilities if interest rates remain elevated. Its low beta of 0.505 offers defensive appeal but also caps upside potential in strong bull markets. The primary competitive and regulatory risk is the constant need for favorable rate case outcomes across six jurisdictions to earn its authorized returns on a $50B+ asset base; any political or regulatory pushback could compress allowed returns.
Worst-Case Scenario involves a 'perfect storm' where multiple rate cases face delays or unfavorable rulings, concurrently with rising interest rates that increase financing costs on its high debt load. This would squeeze cash flow further, potentially forcing a dividend cut or equity issuance, and trigger a re-rating to a lower multiple. The realistic downside could see the stock retreat to its 52-week low of $41.71, representing a -14% decline from the current price of $48.57. A more severe bear case, incorporating an earnings miss, could push the stock toward the $38-$40 range, implying a potential loss of -18% to -22%.
FAQ
The key risks are, in order of severity: 1) Financial Risk: The company is burning cash at a rate of -$2.28B TTM to fund capital expenditures, requiring continuous external financing. 2) Regulatory Risk: Earnings are dependent on favorable outcomes from rate cases across six states; an adverse ruling could impair returns. 3) Leverage Risk: A debt-to-equity ratio of 1.76 increases sensitivity to rising interest rates. 4) Market Risk: The stock has significantly underperformed the S&P 500 (-21.87% over one year) and could remain out of favor, capping upside.
The 12-month forecast for EXC is a range-bound outcome with a base case target of $48-$51 (60% probability), implying modest upside from the current $48.57. The bull case (25% probability) targets $52-$55, driven by regulatory wins and multiple expansion. The bear case (15% probability) sees a retreat to the $41-$44 range, aligning with its 52-week low, triggered by rate case setbacks. The base case is most likely, assuming the company meets consensus EPS estimates of ~$3.68 and the current valuation multiple holds. The key assumption is that regulatory proceedings remain on track without major surprises.
EXC appears fairly valued relative to its own history and sector. Its trailing P/E of 15.92x sits near the lower end of its historical range (7x to 29x), suggesting it is not overpriced. Compared to the regulated utility sector, which often trades in the 17x-20x P/E range, EXC's multiple implies a slight discount, likely reflecting the market's caution regarding its cash burn and regulatory execution. The valuation implies the market expects stable, low-single-digit earnings growth, which is appropriate for its business model. It is neither screamingly cheap nor excessively expensive.
EXC is a reasonable buy for a specific investor profile: those seeking a defensive, low-volatility holding with a solid 3.67% dividend yield. The stock offers a fair valuation at a forward P/E of 15.9x, which is likely a slight discount to utility peers. However, it is not a compelling growth story, and the significant negative free cash flow (-$2.28B) presents a tangible risk. It is a good buy for income-focused, long-term investors who can tolerate the stock's underperformance in bull markets and are confident in management's ability to execute its capital plan. For traders or growth investors, it is not a good buy.
EXC is unequivocally suitable for long-term investment, not short-term trading. Its low beta (0.505) and dividend income profile are designed for compounding over years. The company's multi-billion dollar, multi-year grid investment program will take time to fully contribute to earnings, and the regulatory approval process is inherently slow. Short-term traders would be frustrated by its low volatility and tendency to trade in a range. A minimum holding period of 3-5 years is suggested to fully realize the benefits of its dividend yield and to allow its capital investment story to potentially play out.